About Syrrx
Syrrx is a company based in San Diego (United States) founded in 1999 was acquired by Takeda in February 2005.. Syrrx has raised $79 million across 4 funding rounds from investors including Canadian Imperial Bank of Commerce, Takeda Pharmaceuticals and SBIR. Syrrx operates in a competitive market with competitors including Gemseki, SARomics Biostructures, Shamrock Structures, PTM Thera and Crelux, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$79 M (USD)
in 4 rounds
-
Latest Funding Round
$100 K (USD), Grant
Oct 15, 2001
-
Investors
Canadian Imperial Bank of Commerce
& 8 more
-
Employee Count
Employee Count
-
Acquired by
Takeda
(Feb 05, 2005)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Syrrx
Syrrx has successfully raised a total of $79M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $100 thousand completed in October 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $100,000
-
First Round
First Round
(01 Aug 2000)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2001 | Amount | Grant - Syrrx | Valuation |
investors |
|
| Jan, 2001 | Amount | Series C - Syrrx | Valuation | Lombard Odier | |
| Oct, 2000 | Amount | Series B - Syrrx | Valuation | MPM Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Syrrx
Syrrx has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, Takeda Pharmaceuticals and SBIR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic investments in US life-sciences sectors are managed.
|
Founded Year | Domain | Location | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Syrrx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Syrrx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Syrrx Comparisons
Competitors of Syrrx
Syrrx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gemseki, SARomics Biostructures, Shamrock Structures, PTM Thera and Crelux, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Delivers advanced solutions for drug discovery and related services.
|
|
| domain | founded_year | HQ Location |
Services in protein crystallography and structure-based drug design are offered.
|
|
| domain | founded_year | HQ Location |
Proteomic services like protein cloning, expression, purification and crystallization
|
|
| domain | founded_year | HQ Location |
Drug development services are provided by PTM Thera.
|
|
| domain | founded_year | HQ Location |
X-ray crystallography and fragment-based drug discovery services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Syrrx
When was Syrrx founded?
Syrrx was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Where is Syrrx located?
Syrrx is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Syrrx a funded company?
Syrrx is a funded company, having raised a total of $79M across 4 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Aug 01, 2000.
What does Syrrx do?
Founded in 1999 and based in San Diego, United States, Syrrx operates in the biotechnology sector. Efforts are directed toward identifying three-dimensional structures of validated drug targets via high-throughput structural biology. Structure-based drug design is applied to develop candidates for metabolic diseases, cancer, and inflammation. A partnership is maintained for commercializing DPP IV inhibitors aimed at type 2 diabetes and related conditions.
Who are the top competitors of Syrrx?
Syrrx's top competitors include Shamrock Structures, SARomics Biostructures and Crelux.
Who are Syrrx's investors?
Syrrx has 9 investors. Key investors include Canadian Imperial Bank of Commerce, Takeda Pharmaceuticals, SBIR, Lombard Odier, and Bay City Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.